Stay updated on Sotatercept in PAH High-Risk Mortality Clinical Trial
Sign up to get notified when there's something new on the Sotatercept in PAH High-Risk Mortality Clinical Trial page.

Latest updates to the Sotatercept in PAH High-Risk Mortality Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedThe page has undergone significant changes, including the removal of detailed study objectives and inclusion criteria for a clinical trial on Pulmonary Arterial Hypertension, while adding new identifiers and a revision number.SummaryDifference29%
- Check34 days agoChange DetectedThe web page has updated its version from v2.14.3 to v2.14.4, and the date has changed from March 25, 2025, to March 20, 2025.SummaryDifference0.2%
- Check41 days agoChange DetectedThe page has been updated to reflect a new last update date of March 25, 2025, and a revision change to version 2.14.3.SummaryDifference0.1%
- Check48 days agoChange DetectedThe webpage has updated its clinical trial information, including the completion date and the duration of the study, while removing outdated details about recruitment status and previous estimated dates.SummaryDifference1%
- Check77 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference0.9%
Stay in the know with updates to Sotatercept in PAH High-Risk Mortality Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sotatercept in PAH High-Risk Mortality Clinical Trial page.